Table 2.
Clinicopathological characteristics of patients with nasopharyngeal carcinoma
| CRT | P value | |||
|---|---|---|---|---|
| Non-residual(n = 28) | Residual(n = 12) | |||
| Age (mean ± SD, years) | 53.04 ± 12.84 | 46.92 ± 11.20 | 0.160 | |
| Gender | Male(n = 31) | 21(67.7%) | 10(32.3%) | 0.447 |
| Female(n = 9) | 7(77.8%) | 2(22.2%) | ||
| Diameter(mm) | 30.35 ± 10.31 | 33.63 ± 8.28 | 0.337 | |
| T stage | T1(n = 3) | 3(100%) | 0 | 0.623 |
| T2(n = 3) | 2(66.7%) | 1(33.3%) | ||
| T3(n = 21) | 15(71.4%) | 6(28.6%) | ||
| T4(n = 13) | 8(61.5%) | 5(38.5%) | ||
| N stage | N0(n = 5) | 3(60.0%) | 2(40.0%) | 0.764 |
| N1(n = 12) | 9(75.0%) | 3(25.0%) | ||
| N2(n = 13) | 10(76.9%) | 3(23.1%) | ||
| N3(n = 10) | 6(60.0%) | 4(40.0%) | ||
| AJCC/UICC stage | II(n = 2) | 2(100%) | 0 | 0.370 |
| III(n = 14) | 11(78.6%) | 3(21.4%) | ||
| IV(n = 24) | 15(62.5%) | 9(37.5%) | ||
| Histology | DNK(n = 15) | 13(86.7%) | 2(13.3%) | 0.074 |
| UNK(n = 25) | 15(60.0%) | 10(40.0%) | ||
| Invasion of the skull base | Yes (n = 23) | 15(65.2%) | 8(34.8%) | 0.431 |
| No (n = 17) | 13(76.5%) | 4(23.5%) | ||
Note: CRT: chemoradiotherapy; AJCC/UICC stage: Nasopharyngeal carcinoma staging was performed according to the 8th edition of the American Joint Committee on Cancer (AJCC stage)/the Union for International Cancer Control (UICC) TNM Classification based on pre-treatment MRI images. DNK: Differentiated non-keratinizing; UNK: Undifferentiated non-keratinizing. P < 0.05 was considered statistically significant.